Quad-C Management has made an investment in Pharm-Olam International, a clinical research organization (CRO) serving the pharmaceutical, biotechnology and medical device industries. Pharm-Olam was founded in 1994 by Dr. Zev Munk, a physician, and Eugene Barg, both of whom have over 20 years of experience in the clinical research field. Dr. Munk and Mr. Barg […]
contract research
Amulet Acquires SynteractHCR
Amulet Capital Partners has acquired SynteractHCR, a contract research organization that supports Phase I‐IV clinical trials for emerging to mid-sized biopharma companies, from Gryphon Investors. SynteractHCR was founded in 1995 and, according to the company, is a top 20 global contract research organization. The company has specific expertise in the oncology, immunotherapy, infectious disease, endocrinology, […]
Nautic Exits Theorem Clinical Research
Nautic Partners has completed the sale of Theorem Clinical Research to Chiltern International, a UK-based contract research organization. Theorem Clinical Research is a full-service contract research organization (CRO) that conducts early phase, Phase II/III and late phase clinical trials for pharmaceutical, biotech and medical device and diagnostic customers. The company is based in King of […]
CCMP Capital Sells Medpace to Cinven
CCMP Capital has sold its portfolio company Medpace, a contract research organization, for $915 million to European private equity firm Cinven. In 2013, Medpace generated an adjusted EBITDA of $94 million resulting in a valuation multiple of 9.7x. CCMP acquired Medpace in May 2011. Medpace is a late-stage focused clinical research organization (CRO) that provides […]